SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-20-005503
Filing Date
2020-03-31
Accepted
2020-03-31 17:27:16
Documents
67
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1770747
2 ex4-7.htm EX-4.7 15553
3 ex23-1.htm EX-23.1 4871
4 ex31-1.htm EX-31.1 13422
5 ex31-2.htm EX-31.2 13430
6 ex32-1.htm EX-32.1 11588
7 form10k_001.jpg GRAPHIC 20572
8 form10k_002.jpg GRAPHIC 15276
9 form10k_003.jpg GRAPHIC 9922
10 form10k_004.jpg GRAPHIC 7892
11 form10k_005.jpg GRAPHIC 8015
12 form10k_006.jpg GRAPHIC 7121
  Complete submission text file 0001493152-20-005503.txt   4620229

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE rttr-20191231.xml EX-101.INS 492053
14 XBRL SCHEMA FILE rttr-20191231.xsd EX-101.SCH 42425
15 XBRL CALCULATION FILE rttr-20191231_cal.xml EX-101.CAL 53462
16 XBRL DEFINITION FILE rttr-20191231_def.xml EX-101.DEF 158906
17 XBRL LABEL FILE rttr-20191231_lab.xml EX-101.LAB 317144
18 XBRL PRESENTATION FILE rttr-20191231_pre.xml EX-101.PRE 243599
Mailing Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067
Business Address 1880 CENTURY PARK EAST, SUITE 1000 LOS ANGELES CA 90067 310-203-1000
RITTER PHARMACEUTICALS INC (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37428 | Film No.: 20762924
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences